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Abstract
Background: The modulation of voltage-dependent Na
+ channels by lipid metabolites such as arachidonic acid or
eicosanoids plays a role in physiological functions as well as in degenerative diseases. So far TTX-resistant channels
were found mainly to be regulated by lipid metabolites.
Results: We investigated the lipid-dependent modulation of TTX-sensitive (TTX-s) Na
+ channels using b-
bungarotoxin (b-BuTX, 10 pM), which has an intrinsic phospholipase-A2 activity, and indomethacin (10 μM), which
blocks cyclooxygenase activity in primary cerebellar neurons. To investigate TTX-s Na
+ channels, whole-currents
were measured under K
+-free conditions and blocked by 10 nM TTX. The currents resulting from calculating the
difference of currents measured in the presence and the absence of TTX were used for further analysis. Application
of indomethacin mainly changed the current kinetics but has only minor effects on voltage-dependence. In
contrast b-BuTX increased the maximal current amplitude and shifted the voltage-dependent activation towards
more negative potentials. The effects of b-BuTX were blocked by indomethacin. Analysis of lipid metabolites which
accumulate by treatment with b-BuTX using MALDI-TOF MS showed an increase of cyclooxygenase reaction
products in relation to arachidonic acid.
Conclusions: In summary, we conclude that TTX-sensitive Na
+ channels can be directly modulated by
cyclooxygenase reaction products leading to higher activity at less depolarized potentials and subsequent higher
excitability of neurons. Since activation of cyclooxygenase is also involved in pathways leading to apoptotic cells
death this could play a role in degenerative diseases of the CNS and highlights a possible protective effect of
cyclooxygenase inhibition.
Background
Na
+ channels are known to be modulated by lipid meta-
bolites, such as arachidonic acid or prostaglandins.
These modulations serve physiological functions such as
neurotransmitter-dependent change in excitability, pain
generation or inflammation-dependent hyperalgesia
[1-7]. Also in degenerative processes the modulation of
Na
+ channels by prostaglandins plays a role. In cerebral
ischemia, neuronal cell death can be caused by excito-
toxicity, which is based on strong depolarization and
over-excitation of neurons [1,2,6,8]. The increase in Na
+
channel activity by lipid metabolites might further con-
tribute to the over-excitation.
Both tetrodotoxin-sensitive (TTX-sensitive or TTX-s)
Na
+ channels and TTX-resistant (TTX-r) Na
+ channels
are modulated by either arachidonic acid or eicosanoids
[5,9]. In contrast to TTX-s Na
+ channels, the interaction
of TTX-r Na
+ channels and eicosanoids has been so far
well characterized. The increase of TTX-r Na
+ channel
activity by prostaglandins is known to be involved in
hyperalgesia [2,4]. However, the effects of prostaglandins
on Na
+ channel currents were found to be rather
mediated by G-proteins. Direct application of arachido-
nic acid reduces Na
+ channel activity by changing the
maximal current amplitude, influencing Na
+ current
inactivation kinetics and shifting the voltage-dependent
activation [5,10,11]. These effects seem to be one of the
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rotransmitter release and reduction of Na
+-dependent
action potentials [10]. The effects of arachidonic acid
could be blocked by cyclooxygenase inhibitor indometha-
cin [5]. Thus the effects of arachidonic acid seem to be
more mediated by the metabolites of arachidonic acid.
Lipid metabolites are also known to contribute to
apoptotic cell death in several degenerative diseases
including ischemia [1,2,12,13]. In order to study
mechanisms leading to apoptosis, animal toxins were
often used. In this respect, the application of b-bungaro-
toxin (b-BuTX) is one of the most established models
[14-21]. b-BuTX is a component of the venom of the
Taiwanese banded krait Bungarus muticinctus.T h e
toxic effect of b-BuTX is related to its intrinsic phos-
pholipase-A2 activity [14,15]. The mechanisms trigger-
ing neuronal cell death via b-BuTX include the increase
in intracellular free Ca
2+, increased Ca
2+ influx through
NMDA-receptors, caspase-3 activation, production of
reactive oxygen species and NO production, as well as K
+ channel inhibition [16-20,22-27].
The modulation of Na
+ channels by lipid metabolites
serves many functions but was analyzed only in detail
for TTX-r Na
+ channels. The effects on TTX-s Na
+
channels were so far less investigated and the effects of
b-BuTX as a model for apoptotic cell death had not
been investigated on the activity of Na
+ channels,
although Na
+ channel modulation by lipids could play a
role in over-excitation. Therefore, the aim of the study
was to investigate the effects of the modulators of lipid
metabolism indomethacin and b-BuTX on TTX-s Na
+
channels in rat cerebellar neurons. For this purpose,
TTX-sensitive whole-cell currents were measured from
primary cerebellar granule neurons (CGN) under expo-
sure to b-BuTX and indomethacin. Matrix-assisted
laser-desorption-ionization time-of-flight mass spectro-
metry (MALDI-TOF MS) was used to determine
changes in lipid metabolites.
Results
Under K
+-free conditions, depolarization of CGN cells
from a holding potential of -70 mV led to the activation
of fast activating and inactivating inward currents.
These currents activated at potentials more positive
than -40 mV which peaked at -10 mV. Application of
tetrodotoxin (TTX; 10 nM) completely blocked these
currents. Thus these currents could be identified as cur-
rents through neuronal voltage-dependent Na
+ channels.
Under these conditions the TTX-sensitive current was
90.0 ± 1.2% (n = 7). In order to analyze the effects of b-
BuTX on pure TTX-sensitive currents, in all cells of the
experiments shown here, we used only the currents
which resulted from subtraction of the currents mea-
sured before TTX application from those currents
m e a s u r e di nt h ep r e s e n c eo fT T Xi nt h es a m ec e l l( F i g -
ure 1A; Additional file 1: Figure S1). Thus only the cur-
rents which were blocked by TTX were further analyzed
and TTX-resistant currents had no influence on data
analysis.
In order to study the influence of eicosanoids on Na
+
channel activity, two substances were used. Indometha-
cin blocks cyclooxygenase which catalyzes the first step
in the production of different eicosanoids from arachi-
donic acid. b-BuTX is known to show intrinsic phos-
pholipase-A2 activity which catalyzes the production of
arachidonic acid. Incubation of cells with indomethacin
(10 μM) mainly led to an acceleration of the time-
dependent activation. In the presence of cyclooxygenase
blocker the current activated much faster by a voltage-
step from -70 mV to -10 mV (Figure 1B). Furthermore,
at the voltages between -10 and 0 mV indomethacin
increased the maximal current density of Na
+ channel
currents (Figure 1C). On the other hand, incubation
with b-bungarotoxin (b-BuTX; 10 pM) increased the
current density and led to a shift in the voltage-depen-
dence towards more negative values (Figure 1D). When
cells were incubated with b-BuTX together with indo-
methacin the TTXs Na
+ channel current amplitudes
were smaller and voltage-dependence was shifted
towards more positive values compared to the currents
measured in the presence of b-BuTX alone (Figure 1E).
Thus inhibition of cyclooxygenase by indomethacin was
able to block the effects of b-BuTX. b-BuTX seems to
favorably affect Na
+ channels. Voltage-dependent Ca
2+
channels showed changes neither in current density nor
in voltage-dependence in the presence of 10 pM b-
BuTX (Additional file 2: Figure S2).
In order to compare the effects of indomethacin and
b-BuTX on voltage-dependence of Na
+ channel currents
normalized current/voltage plots were fitted using the
Boltzmann equation and fitting parameters were com-
pared under each experimental condition (Figure 2A
and 2B). The activation threshold was not changed by
either indomethacin or b-BuTX (Figure 2C). However,
the voltage of maximal current amplitude was shifted
towards more negative membrane potentials by b-
BuTX, which could be blocked by indomethacin,
whereas indomethacin alone had no significant effect on
the voltage of maximal current amplitude (Figure 2D).
The Boltzmann analysis of voltage-dependence revealed
that the change in the voltage of maximal current
amplitude was due to a shift of the voltage of half maxi-
mal activation towards more negative voltages in the
presence of b-BuTx (Figure 2E). Again, this effect could
be blocked by the application of indomethacin, while
indomethacin itself had no effect on the voltage of max-
imal activation. Furthermore, b-BuTX significantly
reduced the slope factor of the current/voltage curve
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Figure 1 Effects of indomethacin and b-bungarotoxin on TTX-sensitive currents in cerebellar neurons. 1A: Example of TTX-sensitive
currents: currents were activated by depolarization of cells from a holding potential of -70 mV in nine voltage-steps with 10 mV increasing amplitude
and 50 ms duration; currents were measured in the presence and in the absence of TTX (10 nM). Currents measured in before application of TTX were
subtracted from currents measured in the presence of TTX and used for further analysis. 1B: Effect of indomethacin (10 μM): currents were stimulated
by a voltage-step from -70 mV to -10 mV and plotted as relative current to the maximal current amplitude. Indomethacin led to a faster time-
dependent activation. 1C: Effect of indomethacin on TTX-sensitive Na
+ currents: current density was plotted against the potentials of the electrical
stimulation. Indomethcin led to increased current density. 1D: Effect of b-Bungarotoxin (b-BuTX, 10 pM) on TTX-sensitive currents. Currents were
normalized to the membrane capacitance and plotted as current density against the potentials of the electrical stimulation. 1E: Inhibition of b-BuTX
effects by indomethacin: currents were measured in the presence of either b-BuTX or in the presence of b-BuTX together with indomethacin; current
density was calculated and plotted against the potentials of the electrical stimulation. (* p < 0.05).
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Figure 2 Analysis of changes in voltage-dependence of TTX-sensitive currents by indomethacin and b-bungarotoxin. 2A: Effect of b-
BuTX on voltage-dependence by current/voltage-relationships: currents were normalized to the maximal current amplitude and plotted against the
potentials of the electrical stimulation. Curves were fitted using the Boltzmann equation. In the presence of b-BuTX the voltage-dependent activation
was shifted towards more negative potentials. 2B: Effect of indomethacin and b-BuTX on voltage-dependence by current/voltage-relationships:
relative currents were plotted against the membrane potentials; curves were fitted using the Boltzmann equation. Indomethacin reversed the effect of
b-BuTX. 2C: Comparison of activation thresholds from the current voltage-relationships: neither b-BuTX nor indomethacin showed any effect on
activation threshold. 2D: Comparison of the potentials of maximal current amplitude obtained from current/voltage-relationships. In the presence of
b-BuTX the maximal current amplitude was observed at much more negative potentials. 2E: Comparison of potentials of half maximal activation
obtained from Boltzmann fits; b-BuTX shifted the voltage-dependent activation towards more negative voltages which was reversed by indomethacin.
2F: Comparison of the slope-factors of current/voltage-relationships obtained from Boltzmann fits; with b-BuTX the curves were much steeper than
under control conditions which could be reversed by indomethacin. (*p <0 . 0 5 ;* * p < 0.01; ***p <0 . 0 0 1 ) .
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Page 4 of 10indicating a remarkable increase in current amplitude
with depolarizing membrane voltages (Figure 2F). This
effect was blocked by indomethacin whereas indometha-
cin alone had no effect on the slope factor. Thus b-
BuTX shifted the voltage-dependence of Na
+ channels
towards more negative membrane voltages leading to an
increase in Na
+ currents to larger current amplitudes
with depolarizing voltages.
As shown in Figure 1 indomethacin and b-BuTX had
also effects on the activation kinetics of the Na
+ cur-
rents. For a thorough analysis of the Na
+ kinetics we
plotted the activation time constants and the inactiva-
tion time constants against the test voltages of the sti-
mulation protocol (Figure 3A). The activation time
constants and the inactivation time constants were esti-
mated using a single exponential fit of the current curve
during activation and inactivation respectively. Here we
found that indomethacin led to faster time-dependent
activation than under control conditions which could
not be reversed by b-BuTX which alone has no effect
on the time-dependent activation (Figure 3A). On the
other hand, either indomethacin or b-BuTX had no
effects on the time-dependent inactivation (Figure 3B).
b-BuTX has an intrinsic phospholipase-A2 activity
which may lead to an accumulation of intracellular ara-
chidonic acid or increased formation of metabolic pro-
ducts of arachidonic acid, catalyzed e.g. by
cyclooxygenase or lipoxygenase. Since indomethacin, a
cyclooxygenase inhibitor reverses the b-BuTX-induced
increase in Na
+ channel currents it is likely that the b-
BuTX -effect is mediated by cyclooxygenase reaction
products. Thus we examined the reaction products of
cyclooxygenase which arose from treatment of cells with
b-BuTX using MALDI-TOF MS techniques (Figure 4).
The semi quantitative analysis of the reaction products
concentrated on cyclooxygenase products from arachi-
donic acid and determined as ratio between reaction
products and arachidonic acid. Arachidonic acid was
measured at m/z 304 whereas the reaction products
were measured at m/z 352. As a result we found that
treatment with b-BuTX increased the amount of these
reaction products in relation to the arachidonic acid
concentration. Thus the major effect of b-BuTX on
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Figure 3 Analysis of changes in the time-dependent activation
of TTX-sensitive currents by b-BuTX or indomethacin. 3A:
Comparison of the activation time constants: activation time constants
were estimated by single exponential fits for each voltage.
Indomethacin led to acceleration of the time-dependent activation
which could not reversed by b-BuTX. 3B: Comparison of the
inactivation time constants: inactivation time constants were estimated
by single exponential fits and plotted against the membrane
potentials. Neither b-BuTX nor indomethacin showed any influence on
time-dependent inactivation. (* p < 0.05; **p < 0.01; ***p < 0.001).
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metabolites of arachidonic acid in neurons under influence of
b-bungarotoxin. 4A: Ratio of relative signal intensities of
arachidonic acid metabolites to arachidonic acid was calculated for
each individual spectrum after MALDI-TOF analysis. 4B: Table of
mass signals of different eicosanoids in the MALDI-TOF spectrum.
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Page 5 of 10arachidonic acid metabolism was not an accumulation
of arachidonic acid, but an increase of the level of its
reaction products prostacyclin, prostaglandin and/or
thromboxane. It should be mentioned that this method
did not enable us to measure absolute concentrations.
Discussion
In this paper we analyzed the effects of reaction pro-
ducts of lipid metabolism on Na
+ channel activity in
neurons. For this purpose two substances that change
the lipid metabolism were used: indomethacin, which
inhibits cyclooxygenase and b-BuTX a peptide from
snake venom with intrinsic phospholipase-A activity.
We could show that Na
+ channel activity is sensitive to
cyclooxygenase reaction products of arachidonic acid.
These reaction products enhanced the Na
+ activity by
increasing the maximal current amplitude and shifts of
the voltage-dependent activation towards more negative
potentials.
In order to analyze the activity of voltage-dependent
Na
+ channels depolarization-induced whole-cell currents
from cerebellar neurons were measured in the presence
and absence of TTX under K
+-free conditions in all
cells. After subtraction of the currents, which were mea-
sured in the presence of TTX from those measured in
the absence of TTX, the currents blocked by TTX were
calculated. Further data analysis was only done using
the subtracted currents. Since we used 10 nM TTX to
inhibit voltage-dependent Na
+ channel currents, only
TTX-s Na
+ channels were investigated [28]. These
TTX-sensitive currents were used for further analysis
of Na
+ channel activity under influence of lipid
metabolites.
As a first result we found that after inhibition of
cyclooxygenase activity the time-dependent activation
was faster and increased the maximal current amplitude
at depolarized potentials than under control conditions.
This could be either due to an accumulation of sub-
strates of cyclooxygenase or a decrease of its reaction
products. The main substrate of cyclooxygenase reaction
is arachidonic acid. Thus the effects of cyclooxygenase
inhibition are possibly due to an increase in arachidonic
acid level. Studies which examined the effects of arachi-
donic acid on Na
+ channel activity could show that
extracellular application of arachidonic acid alone has
an inhibitory effect. Extracellular application of arachi-
donic acid led to faster time-dependent inactivation,
shifts in the voltage-dependence and smaller Na
+ cur-
rent amplitude in dorsal root ganglion cells and in stria-
tal neurons [5,10]. TTX-r Na
+ channels in cardiac cells
also showed a reduced current amplitude and voltage-
dependence as a direct effect of arachidonic acid [11].
The effects of arachidonic acid were found to be caused
partly by arachidonic acid itself and partly by
arachidonic metabolites [5,11]. However, a recent paper
showed that intracellular application of arachidonic acid
leads to an increase in the Na
+ channel amplitude. Since
we observed a higher maximal current and a faster
time-dependent activation Na
+ channels, the effect of
cyclooxygenase inhibition is rather due to an increase of
intracellular arachidonic acid concentration [29]. It
should be noted that indomethacin is a non-selective
blocker which cannot differentiate between cyclooxygen-
ase-1 and -2 [30,31]. The effects of indomethacin alone
were observed in un-stimulated cells and could be more
due to inhibition of cyclooxygenase-1.
For the first time, we investigated the effects of b-
BuTX on the Na
+ currents in cerebellar neurons. Inter-
estingly, we found that treatment with b-BuTX led to
no changes in the current kinetics but to an increase in
the maximal current amplitude and to a shift of the vol-
tage-dependent activation towards more negative poten-
tials. Thus b-BuTX treatment led to the activation of
Na
+ channels at negative potentials and led to larger
current amplitudes. In summary, b-BuTX effects would
lead to an increase of excitability of cerebellar neurons.
In general, the increase in excitability would correspond
to a toxic action of b-BuTX by inducing neurotoxicity
which is based on over-excitation of the neurons invol-
ving NMDA receptors [14,16,20,22,27,32]. In addition to
that, by its phospolipase activity b-BuTX leads to apop-
tosis. Here, as a second effect, the products of phospho-
lipase activity directly promote the signaling cascade
leading to apoptosis [14-16,19,22,32]. Then the modula-
tion of Na
+ channels to a higher activity would be a
synergistic effect enhancing neurotoxicity.
90% of the whole-cell currents were TTX-sensitive
currents. The remaining TTX-resistant currents
resembled voltage-dependent Ca
2+ channel currents. Na
+ channels and Ca
2+ channels are closely related in their
structures. Thus we tested whether b-BuTX also influ-
enced ion channels which are accounting for the TTX-
resistant part of the whole-cell currents under K
+-condi-
tions. Interestingly b-BuTX did not change the activity
of voltage-dependent Ca
2+ channels. Taking into
account the analysis method and the fact under our
recording conditions only Na
+ channels were affected by
b-BuTX we conclude that activation of lipid metabolism
by b-BuTX favorably modulates TTX-s Na
+ channels.
However, a possible influence on other ion channels
such as K
+ channels, Cl channels or ionotropic neuro-
transmitter receptors cannot be excluded.
The effects of b-BuTX were inhibited by treatment
with indomethacin, indicating that the inhibition of
cyclooxygenase reverses the effects of b-BuTX. This
observation suggests the involvement of lipid molecules
in b-BuTX-dependent increase in Na
+ channel activity.
The b-BuTX phospholipase activity leads to the
Guo et al. BMC Neuroscience 2012, 13:36
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Page 6 of 10production of arachidonic acid. Arachidonic acid can be
metabolized by lipoxygenase and by cyclooxygenase.
Since indomethacin can block the effects of b-BuTX,
products of the cyclooxygenase pathway are responsible
for the modulation of Na
+ channel activity. In this way
indomethacin cannot be regarded as an antagonist of
the b-BuTX. This hypothesis is supported by comparing
the effects of indomethacin and b-BuTX on Na
+ chan-
nel current amplitude. Both led to an increase in current
amplitude but indomethacin at voltages between -10
and 0 mV and b-BuTX at voltages between -40 and -20
mV. Furthermore, indomethacin accelerated the time-
dependent activation whereas b-BuTX had no effects on
current kinetics. Thus, both effects possibly result from
different metabolites. The effect from indomethacin pos-
sibly results from arachidonic acid and the effect of b-
BuTX results from cyclooxygenase reaction products.
Moreover, this hypothesis is further supported by our
observations from MALDI-TOF MS analysis of lipid
metabolites arising from incubation with b-BuTX. Since
cyclooxygenase metabolizes arachidonic acid and the
effects of b-BuTX were blocked by cyclooxygenase inhi-
bitor we performed a relative quantification of the
cyclooxygenase products versus arachidonic acid. As a
result we found that b-BuTX led to an increase of the
cyclooxygenase products in relation to arachidonic acid.
Arachidonic acid is a reaction product of phospholipase-
A which can be metabolized by lipoxygenase or by
cyclooxygenase. Although MALDI-TOF MS analysis
enabled us only measure relative amount and no abso-
lute concentrations our finding, however, suggests that a
considerable amount of arachidonic acid is quickly
metabolized by cyclooxygenase. Thus, incubation of cer-
ebellar neurons with b-BuTX directly leads to an
increase of cyclooxygenase reaction products. Thus, in
summary, the b-BuTX effects on Na
+ channel activity
are then due to cyclooxygenase reaction products.
Application of b-BuTX to neurons was used as a model
to investigate cellular mechanisms related to apoptosis
during neurotoxicity. The effects of b-BuTX on Na
+
channel activity could be interpreted as an increase in
excitability of the neurons which also represents a basic
mechanism in neurotoxicity. This is supported by the
knowledge that cyclooxygenase products are involved in
promoting cell death in neurotoxicity. Since indometha-
cin could prevent the effects of b-BuTX, indomethacin
may have a beneficial effect on neurotoxicity in general.
Cyclooxygenase inhibition is used in early treatment of
stroke, possibly this treatment has more beneficial effects
than currently known. This study provides experimental
evidence for such a mechanism by which indomethacin
prevents cyclooxygenase reaction products dependent
increase in excitability of neurons.
Conclusions
I ns u m m a r yw ec o n c l u d et h a tb-BuTX enhances the
activity of TTX-sensitive Na
+ channels in cerebellar
neurons. Since cyclooxygenase inhibition reversed the
effect of b-BuTX was due to cyclooxygenase reaction
products. Thus the inhibition of cyclooxygenase could
reduce excitability of neurons acting at the Na
+ channel
side and therefore beneficial to reduce neurotoxicity.
Methods
Preparation of primary neuronal culture
Rat CGNs were prepared from 1-4 days old BDE (black
hooded) rats. Cerebelli were isolated from rats and stored
in PBS on ice. After centrifugation (3 min, 800 rpm), PBS
was discarded. Subsequently cerebellar granule cells were
dissociated by 0.01% papain in the presence of 0.1% Dis-
pase II and 0.01% DNase for 30 min. The tissue was tritu-
rated gently with glass pipettes twice for dissociation.
Dissociated cells were pelleted by centrifugation (800
rpm for 3 min), and were washed twice by DMEM/Han’s
F12 medium with 10% FCS gold, 1% penicillin/strepto-
mycin. 70 μm cell strainers were used to remove undi-
gested tissue. Cells were re-suspended in DMEM/Ham’s
F12 medium with 10% FCS gold, 1% penicillin/strepto-
mycin, and were plated on poly-L-lysine-coated glass
coverslips in 24-well culture plates. Cultures were main-
tained at 37°C in a humidified atmosphere with 5% CO2.
One day after plating, culture medium was changed to
SFM (serum free), in which FCS gold was replaced by 2%
B-27 supplement. Five micromolar cytosine arabinoside
w a sa l s oa d d e dt ot h ec u l t u r em e d i u mt oa r r e s tt h e
growth of non-neuronal cells. All experiments were per-
formed using CGNs cultured at least for 7 days. All cell
culture media, nutrients and supplements were pur-
chased from PAA (Pasching, Austria).
Whole-cell recordings of Na
+ channels currents
Cells attached to a coverslip were transferred into a
recording chamber on the stage of an inverted micro-
scope. Ionic currents were recorded under voltage-
clamp conditions by the perforated whole-cell patch
clamp technique using nystatin as ionophor. Glass pip-
ettes were pulled from borosilicate glass tubes
(GB150T-8P, Science Products, Germany) to give a
resistance of 3-4.5 MΩ using DMZ Universal Puller
(Zeitz Ausgburg Germany). The external solution con-
tained 130 mM NaCl, 5 mM CsCl, 4 mM MgCl2,2m M
CaCl2, 10 mM HEPES and 5 mM Glucose at pH 7.3.
The internal solution contained 140 mM CsCl, 2 mM
MgCl2,1m MC a C l 2, 2.5 mM EGTA, 10 mM HEPES,
adjusted to pH 7.3. Recordings were performed at room
temperature and cells were held at -70 mV. Whole cell
currents were acquired with an EPC 7 amplifier (HEKA
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tronics Inc., Germany) software. Tetrodotoxin (Alomone
Labs, Ltd., Jerusalem, Israel) was dissolved in Millipore
water as 3.23 mM stock solution and stored at -20°C.
Tetrodotoxin was diluted in external solution to 10 nM
before the experiment. Nystatin (Sigma-Aldrich Chemie
Gmbh, Munich, Germany) used for perforated patch
was dissolved in DMSO as 25 mg/ml stock solution,
which were stored at 4°C for 1 day. Nystatin can be
used for 3 hours after diluted in internal solution to 175
μg/ml. Currents through voltage-dependent Ca
2+ chan-
nels were measured using the same solutions with extra-
cellular 10 mM Ba
2+ as a charge carrier and 10 nM
TTX to block Na
+ channels. The currents were acti-
vated using the same electrical stimulation as for the
measurement of Na
+ channel currents.
Application of b-bungarotoxin and indomethacin
b-bungarotoxin and indomethacin (Sigma-Aldrich Che-
mie GmbH, Munich, Germany) were solved in water
and directly applied to the extracellular solution.
According to Tseng et al. maximal effects on membrane
permeability for Ca
2+ without leading to cell death was
observed after 2 h [25]. Therefore, cells were incubated
for 2 h in either extracellular solution alone, extracellu-
lar solution with b-bungarotoxin (10 pM), indomethacin
(10 μM) or both substances for 2 h prior to the mea-
surements of Na
+ channel currents.
MALDI-TOF MS analysis of arachidonic acid and its
metabolites
After treatment, cells were immediately frozen in liquid
nitrogen and stored at -80°C. After thawing, tissue sam-
ples were homogenized and sonicated. Lipids were sub-
jected to classical chloroform/methanol extraction [33],
transferred to a clean tube, and dried in a vacuum cen-
trifuge and subsequently resolved (2% w/v) in chloro-
form. For MALDI-TOF MS, samples were mixed with
matrix consisting of 0.5 M 2,5-dihydroxybenzoic acid in
methanol with 0.1% trifluoroacetic acid [34]. Aliquots
were spotted on a steel target allowed to dry at ambient
temperature and subjected to mass spectrometrical ana-
lysis. Mass spectra were obtained using an Autoflex
MALDI-TOF MS (Bruker Daltonics, Bremen, Germany)
equipped with a nitrogen laser (l = 337 nm). Mass spec-
tra were acquired in reflectron and positive ion mode.
Each spectrum consists of the average of 100 laser shots.
For the semi-quantitative analysis of arachidonic acid
and its metabolites prostacyclin I2, prostaglandin H2
and thromboxane A2, the relative intensities of mass
signals [M + H
+] were determined and added up.
Obtained m/z values were compared to the lipid data-
base LIPID MAPS http://www.lipidmaps.org/. The ratio
of relative signal intensities of arachidonic acid
metabolites to arachidonic acid was calculated for each
individual spectrum, and averaged over three individual
samples.
Data analysis
Patch clamp data were analyzed by TIDA 5.22 (HEKA
electronics Inc., Germany) software and SigmaPlot (Jan-
del Scientific, San Rafael, CA) software. To analyze vol-
tage-dependence of channel activation, the current-
voltage relationships were fitted according to Boltzmann
equation.
I =

1 + exp (V0.5 − V)/k
−1
I is current through ion channels, V0.5 is the potential
at which I is half-maximum, V is test potential, and k is
the slope factor of the Boltzmann term. The accuracy of
fit was determined by coefficient of determination, R
2.
T h et i m ec o u r s eo fc u r r e n tinactivation was fitted
according to an exponential function.
I(t) = a × exp(−t/τ)+c
I(t)i st h ec u r r e n ta tt i m et after the peak of sodium
current; a is the coefficient of activation; τ is the inacti-
vation time constant; and c is the maximal current.
Activation time of current was measured in TIDA 5.22.
The time at which peak current appeared was sub-
tracted by the beginning of stimulation. Threshold and
the potential which evoked peak current were analyzed
by using raw data.
Statistics
All data are presented as mean ± SEM and “n” refers
the number of experiments. Current/voltage-relation-
ships were plotted and fitted using the Boltzmann equa-
tion for each individual cell. Values of each individual
Boltzmann fit were used for statistical analysis. Statisti-
cal significance was determined by P < 0.05 (*), P < 0.01
(**), and P < 0.001 (***) using student’s t-test.
Additional material
Additional file 1: Figure S1 Isolation of TTX-sensitive currents. A:
Electrical stimulation: The cells were electrically stimulated by 10
depolarizing voltage-steps of 50 ms duration with 10 mV increasing
amplitude from a holding potential of -70 mV. B: Whole-cell currents
measured under K
+-free conditions: Voltage-dependent currents elicited
by the electrical stimulation shown in A. C: Voltage-dependent currents
in the presence of 10 nM TTX: Whole-cell currents from the same cell as
shown B. D: TTX-sensitive currents resulting from subtraction of the
currents shown in B and C.
Additional file 2: Figure S2 Effects of b-BuTX on voltage-dependent
Ca
2+ channels. A: Currents through voltage-dependent Ca
2+ channels
were measured under extra- and intracellular K
+-free conditions in the
presence of 10 mM Ba
2+ as a charge carrier and 10 nM TTX to block Na
+
channel currents. The cells were electrically stimulated by 10 depolarizing
voltage-steps of 50 ms duration with 10 mV increasing amplitude from a
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2+ the electrical
stimulation results in fast activating and slowly inactivating inward
currents. C: Current/voltage plot showing the effects of 10 pM b-BuTX
on Ba
2+ currents. The currents activated at -40 mV and reached maximal
current amplitude at 0 mV. The currents were inhibited by 20% after
application of 10 μM (+)BayK8644 indicting that several types of high-
voltage activated Ca
2+ channels contribute to the Ba
2+ currents.
Application of b-BuTX did change neither current density nor voltage-
dependence of the Ba
2+ currents.
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